Cargando…

Human papillomavirus vaccination in low- and middle-income countries: progression, barriers, and future prospective

Human papillomavirus (HPV) is a viral infection that, if does not go away, can cause health problems like genital warts and cancer. The national immunization schedules for individuals before sexual debut, significantly decreased HPV-associated mortality and it will be affordable. However, immunizati...

Descripción completa

Detalles Bibliográficos
Autores principales: Ebrahimi, Narges, Yousefi, Zahra, Khosravi, Gholamreza, Malayeri, Fatemeh Eskandari, Golabi, Marjan, Askarzadeh, Monireh, Shams, Mohammad Hossein, Ghezelbash, Behrooz, Eskandari, Nahid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227716/
https://www.ncbi.nlm.nih.gov/pubmed/37261366
http://dx.doi.org/10.3389/fimmu.2023.1150238
_version_ 1785050832967827456
author Ebrahimi, Narges
Yousefi, Zahra
Khosravi, Gholamreza
Malayeri, Fatemeh Eskandari
Golabi, Marjan
Askarzadeh, Monireh
Shams, Mohammad Hossein
Ghezelbash, Behrooz
Eskandari, Nahid
author_facet Ebrahimi, Narges
Yousefi, Zahra
Khosravi, Gholamreza
Malayeri, Fatemeh Eskandari
Golabi, Marjan
Askarzadeh, Monireh
Shams, Mohammad Hossein
Ghezelbash, Behrooz
Eskandari, Nahid
author_sort Ebrahimi, Narges
collection PubMed
description Human papillomavirus (HPV) is a viral infection that, if does not go away, can cause health problems like genital warts and cancer. The national immunization schedules for individuals before sexual debut, significantly decreased HPV-associated mortality and it will be affordable. However, immunization programs remain vulnerable to macroeconomic factors such as inflation, fiscal policy, employment levels, and national income. This review aims to investigate the association between national income in lower-middle-income countries to explore recent advances and potential issues, as well as how to deal with challenges.
format Online
Article
Text
id pubmed-10227716
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102277162023-05-31 Human papillomavirus vaccination in low- and middle-income countries: progression, barriers, and future prospective Ebrahimi, Narges Yousefi, Zahra Khosravi, Gholamreza Malayeri, Fatemeh Eskandari Golabi, Marjan Askarzadeh, Monireh Shams, Mohammad Hossein Ghezelbash, Behrooz Eskandari, Nahid Front Immunol Immunology Human papillomavirus (HPV) is a viral infection that, if does not go away, can cause health problems like genital warts and cancer. The national immunization schedules for individuals before sexual debut, significantly decreased HPV-associated mortality and it will be affordable. However, immunization programs remain vulnerable to macroeconomic factors such as inflation, fiscal policy, employment levels, and national income. This review aims to investigate the association between national income in lower-middle-income countries to explore recent advances and potential issues, as well as how to deal with challenges. Frontiers Media S.A. 2023-05-12 /pmc/articles/PMC10227716/ /pubmed/37261366 http://dx.doi.org/10.3389/fimmu.2023.1150238 Text en Copyright © 2023 Ebrahimi, Yousefi, Khosravi, Malayeri, Golabi, Askarzadeh, Shams, Ghezelbash and Eskandari https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Ebrahimi, Narges
Yousefi, Zahra
Khosravi, Gholamreza
Malayeri, Fatemeh Eskandari
Golabi, Marjan
Askarzadeh, Monireh
Shams, Mohammad Hossein
Ghezelbash, Behrooz
Eskandari, Nahid
Human papillomavirus vaccination in low- and middle-income countries: progression, barriers, and future prospective
title Human papillomavirus vaccination in low- and middle-income countries: progression, barriers, and future prospective
title_full Human papillomavirus vaccination in low- and middle-income countries: progression, barriers, and future prospective
title_fullStr Human papillomavirus vaccination in low- and middle-income countries: progression, barriers, and future prospective
title_full_unstemmed Human papillomavirus vaccination in low- and middle-income countries: progression, barriers, and future prospective
title_short Human papillomavirus vaccination in low- and middle-income countries: progression, barriers, and future prospective
title_sort human papillomavirus vaccination in low- and middle-income countries: progression, barriers, and future prospective
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227716/
https://www.ncbi.nlm.nih.gov/pubmed/37261366
http://dx.doi.org/10.3389/fimmu.2023.1150238
work_keys_str_mv AT ebrahiminarges humanpapillomavirusvaccinationinlowandmiddleincomecountriesprogressionbarriersandfutureprospective
AT yousefizahra humanpapillomavirusvaccinationinlowandmiddleincomecountriesprogressionbarriersandfutureprospective
AT khosravigholamreza humanpapillomavirusvaccinationinlowandmiddleincomecountriesprogressionbarriersandfutureprospective
AT malayerifatemeheskandari humanpapillomavirusvaccinationinlowandmiddleincomecountriesprogressionbarriersandfutureprospective
AT golabimarjan humanpapillomavirusvaccinationinlowandmiddleincomecountriesprogressionbarriersandfutureprospective
AT askarzadehmonireh humanpapillomavirusvaccinationinlowandmiddleincomecountriesprogressionbarriersandfutureprospective
AT shamsmohammadhossein humanpapillomavirusvaccinationinlowandmiddleincomecountriesprogressionbarriersandfutureprospective
AT ghezelbashbehrooz humanpapillomavirusvaccinationinlowandmiddleincomecountriesprogressionbarriersandfutureprospective
AT eskandarinahid humanpapillomavirusvaccinationinlowandmiddleincomecountriesprogressionbarriersandfutureprospective